Genome-wide mutational analyses identified cancer gene variants in CML at diagnosis, with ASXL1 being the most frequently mutated gene (9%) in patients with CML at diagnosis [132]. Here, ASXL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.